|
Market Closed -
Nasdaq
21:00:00 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.150 USD | -4.87% |
|
-12.60% | +31.90% |
| 10-06 | Guggenheim Initiates Ovid Therapeutics at Buy | MT |
| 09-20 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to S&P Global BMI Index | CI |
| Market Cap | 441M 392M 364M 331M 624M 41.89B 634M 4.37B 1.71B 21.86B 1.66B 1.62B 69.69B | P/E 2026 * |
-6.26x | P/E 2027 * | -5.86x |
|---|---|---|---|---|---|
| Enterprise Value | 314M 279M 259M 236M 445M 29.84B 452M 3.11B 1.22B 15.57B 1.18B 1.15B 49.63B | EV / Sales 2026 * |
397x | EV / Sales 2027 * | 592x |
| Free-Float |
93.28% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OVID | Delayed | |
CBOE
| OVID | Real-time | |
|
Boerse Muenchen
| 1OT | Real-time | |
|
Deutsche Boerse AG
| 1OT | Delayed | |
|
Börse Stuttgart
| 1OT | Delayed | |
|
Tradegate
| 1OT | Real-time |
Last Transcript: Ovid Therapeutics Inc.
| 1 day | -4.87% | ||
| 1 week | -12.60% | ||
| Current month | -13.65% | ||
| 1 month | -19.78% | ||
| 3 months | -12.24% | ||
| 6 months | -23.21% | ||
| Current year | +31.90% |
| 1 week | 2.09 |  | 2.49 |
| 1 month | 2.09 | | 2.84 |
| Current year | 1.36 | | 3.1 |
| 1 year | 1.18 | | 3.1 |
| 3 years | 0.24 | | 4.1 |
| 5 years | 0.24 | | 4.14 |
| 10 years | 0.24 | | 15.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 31/12/2025 | |
Charles Carter
DFI | Director of Finance/CFO | 59 | 05/07/2026 |
Zhong Zhong
CTO | Chief Tech/Sci/R&D Officer | - | 27/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barbara Duncan
BRD | Director/Board Member | 61 | 13/06/2017 |
Bart Friedman
BRD | Director/Board Member | 81 | 22/11/2015 |
| Director/Board Member | 77 | 02/03/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/07/26 | Free | Chief Financial Officer | 50,000 | 0.0268% | ||
| 06/07/26 | Other | Chief Financial Officer | 450,625 | 0.2414% | ||
| 07/04/26 | Free | Director | 17,578 | 0.0133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.87% | -12.60% | +36.94% | -43.12% | 441M | |
| -6.60% | -10.93% | +45.08% | +60.01% | 68.98B | |
| -4.09% | +3.12% | +3.71% | +53.50% | 53.15B | |
| +0.03% | +7.21% | +12.52% | +44.46% | 50.83B | |
| -1.53% | +2.70% | +29.72% | +34.13% | 44.61B | |
| -5.97% | -6.22% | +258.21% | +421.57% | 40.57B | |
| -1.34% | +4.12% | +16.05% | +112.18% | 42.53B | |
| +6.53% | +8.02% | +18.98% | +54.58% | 30.95B | |
| -0.90% | -10.91% | +34.11% | -1.83% | 25.44B | |
| -2.76% | -9.54% | -16.53% | -9.55% | 22.66B | |
| Average | -2.18% | +1.03% | +43.88% | +72.59% | 38.02B | |
| Weighted average by Cap. | -2.47% | +1.65% | +46.09% | +89.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 792K 704K 652K 593K 1.12M 75.13M 1.14M 7.84M 3.07M 39.21M 2.97M 2.91M 125M | 326K 289K 268K 244K 461K 30.9M 468K 3.22M 1.26M 16.13M 1.22M 1.2M 51.41M |
| Net income | -66.32M -58.95M -54.64M -49.72M -93.81M -6.29B -95.32M -657M -258M -3.28B -249M -244M -10.47B | -83.13M -73.9M -68.49M -62.32M -118M -7.89B -119M -823M -323M -4.12B -312M -305M -13.13B |
| Net Debt | -127M -113M -105M -95.2M -180M -12.05B -183M -1.26B -493M -6.29B -477M -466M -20.05B | -331M -294M -273M -248M -468M -31.43B -476M -3.28B -1.29B -16.4B -1.24B -1.22B -52.29B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | US$2.150 | -4.87% | 1,325,038 |
| 15/10/26 | US$2.260 | +3.20% | 1,333,287 |
| 14/10/26 | US$2.190 | 0.00% | 1,642,457 |
| 13/10/26 | US$2.190 | -9.13% | 1,642,723 |
| 12/10/26 | US$2.410 | -2.03% | 876,042 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OVID Stock
Select your edition
All financial news and data tailored to specific country editions
